Related references
Note: Only part of the references are listed.Ceramide synthases as potential targets for therapeutic intervention in human diseases
Joo-Won Park et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Miglustat: A Review of Its Use in Niemann-Pick Disease Type C
Katherine A. Lyseng-Williamson
DRUGS (2014)
RIPK3 as a potential therapeutic target for Gaucher's disease
Einat B. Vitner et al.
NATURE MEDICINE (2014)
Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Saeid Ghavami et al.
PROGRESS IN NEUROBIOLOGY (2014)
Stuck in traffic: an emerging theme in diseases of the nervous system
Jacques Neefjes et al.
TRENDS IN NEUROSCIENCES (2014)
Competing for the treasure in exceptions
Timothy M. Cox
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Alteration of Ganglioside Biosynthesis Responsible for Complex Hereditary Spastic Paraplegia
Amir Boukhris et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
Gaurav V. Harlalka et al.
BRAIN (2013)
Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C
Y. H. Chien et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability
Charles C. Pontikis et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy
Santosh Chauhan et al.
MOLECULAR CELL (2013)
Therapeutic Response in Feline Sandhoff Disease Despite Immunity to Intracranial Gene Therapy
Allison M. Bradbury et al.
MOLECULAR THERAPY (2013)
Lysosomal impairment in Parkinson's disease
Benjamin Dehay et al.
MOVEMENT DISORDERS (2013)
The role of autophagy in neurodegenerative disease
Ralph A. Nixon
NATURE MEDICINE (2013)
Niemann-Pick disease type C symptomatology: an expert-based clinical description
Eugen Mengel et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Cost-effectiveness of enzyme replacement therapy for Fabry disease
Saskia M. Rombach et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy
A. Bersano et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Gene therapy approaches for lysosomal storage disorders, a good model for the treatment of mendelian diseases
Rosella Tomanin et al.
ACTA PAEDIATRICA (2012)
The case for intrauterine gene therapy
Citra N. Mattar et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2012)
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Frances M. Platt et al.
JOURNAL OF CELL BIOLOGY (2012)
Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C
Veronika M. Stein et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Recommendations for the diagnosis and management of Niemann-Pick disease type C: An update
Marc C. Patterson et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat
Mark Walterfang et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
Nadine A. M. E. van der Beek et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
From Serendipity to Therapy
Elizabeth F. Neufeld
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Diego L. Medina et al.
DEVELOPMENTAL CELL (2011)
Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system
Ahad A. Rahim et al.
FASEB JOURNAL (2011)
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Michela Palmieri et al.
HUMAN MOLECULAR GENETICS (2011)
Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches
Anton I. Rosenbaum et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
N. Matthew Ellinwood et al.
MOLECULAR THERAPY (2011)
Lysosomal Storage Disorders and Parkinson's Disease: Gaucher Disease and Beyond
Tamar Shachar et al.
MOVEMENT DISORDERS (2011)
Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis
Andrew Oberst et al.
NATURE (2011)
Clarifying lysosomal storage diseases
Mark L. Schultz et al.
TRENDS IN NEUROSCIENCES (2011)
HSP70 and lysosomal storage disorders: novel therapeutic opportunities
Nikolaj H. T. Petersen et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Necroptosis as an alternative form of programmed cell death
Dana E. Christofferson et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
Einat B. Vitner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders
Kim M. Hemsley et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid
Benny Liu et al.
JOURNAL OF LIPID RESEARCH (2010)
Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology
Thomas Kirkegaard et al.
NATURE (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Niemann-Pick disease type C
Marie T. Vanier
ORPHANET JOURNAL OF RARE DISEASES (2010)
Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis
Fannie W. Chen et al.
PLOS ONE (2010)
Weekly Cyclodextrin Administration Normalizes Cholesterol Metabolism in Nearly Every Organ of the Niemann-Pick Type C1 Mouse and Markedly Prolongs Life
Charina M. Ramirez et al.
PEDIATRIC RESEARCH (2010)
Lipids on Trial: The Search for the Offending Metabolite in Niemann-Pick type C Disease
Emyr Lloyd-Evans et al.
TRAFFIC (2010)
Lysosomal enhancement A CLEAR answer to cellular degradative needs
Marco Sardiello et al.
CELL CYCLE (2009)
GM1-Ganglioside Accumulation at the Mitochondria-Associated ER Membranes Links ER Stress to Ca2+-Dependent Mitochondrial Apoptosis
Renata Sano et al.
MOLECULAR CELL (2009)
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Paul Saftig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1
David Smith et al.
NEUROBIOLOGY OF DISEASE (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Cristin D. Davidson et al.
PLOS ONE (2009)
Spontaneous appearance of Tay-Sachs disease in an animal model
B. J. Zeng et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
Emyr Lloyd-Evans et al.
NATURE MEDICINE (2008)
Niemann-Pick diseases in adults
F. Sedel
REVUE DE MEDECINE INTERNE (2007)
Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Marc C. Patterson et al.
LANCET NEUROLOGY (2007)
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
O. Goker-Alpan et al.
NEUROLOGY (2006)
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
M. Begona Cachon-Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gaucher disease: multiple lessons from a single gene disorder
Ernest Beutler
ACTA PAEDIATRICA (2006)
Gaucher disease and the synucleinopathies
Kathleen S. Hruska et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Miglustat: Substrate reduction therapy for glycosphingolipid lysosomal storage disorders
RH Lachmann
DRUGS OF TODAY (2006)
Gaucher disease: pathological mechanisms and modern management
M Jmoudiak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice
YP Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
MA Simpson et al.
NATURE GENETICS (2004)
NSAIDs increase survival in the Sandhoff disease mouse:: Synergy with N-butyldeoxynojirimycin
M Jeyakumar et al.
ANNALS OF NEUROLOGY (2004)
Gaucher's disease with Parkinson's disease - Clinical and pathological aspects
B Bembi et al.
NEUROLOGY (2003)
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
N Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Enzyme replacement therapy: conception, chaos and culmination
RO Brady
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2003)
Glycosphingolipid functions: insights from engineered mouse models
RL Proia
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2003)
Biosynthesis and degradation of mammalian glycosphingolipids
K Sandhoff et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2003)
Gaucher disease associated with Parkinsonism:: Four further case reports
J Várkonyi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells
JK Jaiswal et al.
JOURNAL OF CELL BIOLOGY (2002)
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease
RJ Ziegler et al.
HUMAN GENE THERAPY (2002)
Multidrug permeases and subcellular cholesterol transport
YA Ioannou
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Critical role for glycosphingolipids in Niemann-Pick disease type C
M Zervas et al.
CURRENT BIOLOGY (2001)
Gaucher disease and parkinsonism: A phenotypic and genotypic characterization
N Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes
A Reddy et al.
CELL (2001)
Enzyme replacement therapy in Fabry disease
RO Brady et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Fabry disease: Preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice
YA Ioannou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
M Jeyakumar et al.
BLOOD (2001)
Transmembrane molecular pump activity of Niemann-Pick C1 protein
JP Davies et al.
SCIENCE (2000)
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
N Holler et al.
NATURE IMMUNOLOGY (2000)
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis
T Cox et al.
LANCET (2000)
The structure and function of the Niemann-Pick C1 protein
YA Ioannou
MOLECULAR GENETICS AND METABOLISM (2000)
Share Paper
